# Evaluation of Nephure™, and the Reduction of Dietary Oxalate, in Healthy Volunteers

> **NCT03661216** · NA · COMPLETED · sponsor: **Captozyme, Inc.** · enrollment: 33 (actual)

## Conditions studied

- Healthy

## Interventions

- **DIETARY_SUPPLEMENT:** Nephure Oxalate-reducing Enzyme
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03661216
- **Lead sponsor:** Captozyme, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-11
- **Primary completion:** 2018-08-05
- **Final completion:** 2018-08-05
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2018-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03661216

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03661216, "Evaluation of Nephure™, and the Reduction of Dietary Oxalate, in Healthy Volunteers". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03661216. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*